Among the CKI target pathways (except the cell cycle) enriched in SW620 cells, 16 were consistent with our network pharmacology prediction results, and most of them were also consistent with the prediction results of gastric cancer, esophageal cancer, lung cancer, and pan-cancer (Supplementary Table S5). This evidence concerns the gene CHKA and lung cancer.